Diagnostic Evaluation of Sarcopenia in Elderly Patients

Sarcopenia Clinical Trial

Official title:

Development of a New Sarcopenia Screening Tool in the Elderly

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04451005
• Other study ID #: SARC-F
• Status: Completed
• Start date: May 6, 2016
• Est. completion date: December 10, 2019

Study information

• Verified date: June 2020
• Source: University of Sao Paulo
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Sarcopenia is a generalized progressive skeletal muscle disorder that represents a related physiological vulnerability that is associated with or increases the likelihood of adverse outcomes, including falls, fractures, physical disability and death. The parameters used to assess sarcopenia in clinical practice have limited use due to their custody.

In this perspective, this study proposes or develops a tool for the diagnosis of having sarcopenia with a specific boa and a sensitive boa.

low cost and useful.

Elderly patients (n = 403) from the Geriatrics Outpatient Clinic of Hospital das Clínicas, Faculty of Medicine, University of São Paulo will be selected

This study was of clinical importance, due to sarcopenia and a relevant factor, and could lead to consequences and poor prognosis in patients with gold, and it was not a method of clinical practice to properly endorse body composition in this population.

Description:

Sarcopenia is a progressive and generalized skeletal muscle disorder that represents an age-related physiological vulnerability that is associated with an increased likelihood of adverse outcomes, including falls, fractures, physical disability and mortality. The parameters used to assess sarcopenia in clinical practice have limited use due to its cost.

In this perspective, this study proposes the development of a tool for the diagnosis of having sarcopenia with good specificity and good sensitivity and of low cost and useful.

Elderly patients (n = 403) from the Geriatrics Outpatient Clinic of Hospital das Clínicas, Faculty of Medicine, University of São Paulo will be selected. After signing the informed consent, sarcopenia will be assessed using the reference method (DXA) and anthropometry. The data obtained by the methods are treated statistically to obtain correlation and thus a new tool for the evaluation of sarcopenia patients in the elderly can be developed.

This study is of clinical importance, as sarcopenia is a relevant factor and can lead to consequences and poor prognosis in elderly patients, and there is no low-cost method in clinical practice to properly assess body composition in this population.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 403
• Est. completion date: December 10, 2019
• Est. primary completion date: May 6, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• Age = 60 years

• Sign free and informed consent;

• Demonstrate interest, conditions and availability to participate in all procedures included in the study protocol;

Exclusion Criteria:

• Refusal to participate;

• Patients who have not undergone cognitive testing;

• Physical amputation;

• Patients undergoing interventional treatment for sarcopenia;

Related Conditions & MeSH terms

• Sarcopenia

Intervention

Other:
• 0
Elderly patients with sarcopenia

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Sao Paulo

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Sarcopenia in the elderly	Evaluation of sarcopenia in the elderly	12 months
Secondary	Development of a new tool for sarcopenia screening	Development of a new tool for sarcopenia screening	12 months